During the conversion period from 23 June 2025 up to and including 30 June 2025, 3,689,546 ordinary shares were submitted for conversion, representing approximately 4.73 percent of Flerie’s total share capital. According to the Articles of Association, the maximum number of ordinary shares eligible for conversion is capped at a level requiring that the total outstanding shares of series C, following the completion of the conversion, constitute no more than five (5) percent of the Company’s total share capital.

"We created Flerie's voluntary redemption scheme to provide an annual opportunity for liquidity. This is the first time we implement the program and the high utilisation shows that the opportunity has been well received. 'Seeing is believing', so this opportunity to redeem shares at NAV per share should continue to be valued by shareholders," says Ted Fjällman, CEO.

Flerie hereby announces that the Board of Directors, in accordance with the conversion provision in the Articles of Association, has resolved to convert all 3,689,546 ordinary shares that were submitted for conversion into an equivalent number of shares of series C, corresponding to approximately 4.73 percent of the Company’s total share capital.

The conversion is deemed completed once it has been registered with the Swedish Companies Registration Office and recorded in the share register.

After the conversion has been completed, the total number of shares and votes in Flerie will remain 78,066,406. The total number of shares will consist of 74,376,860 ordinary shares and 3,689,546 shares of series C.

Shares of series C carry one vote per share and do not entitle their holders to receive dividends.

As soon as practicable after the publication of the Company’s interim report for the second quarter of 2025, the Board of Directors intends to resolve on the redemption of all outstanding shares of series C. The redemption amount for each share of series C will correspond to its net asset value as of 30 June 2025, as reported in the interim report for the second quarter of 2025.

Flerie’s principal shareholder, Thomas Eldered (through wholly owned companies T&M Förvaltning AB and T&M Participation AB), as well as the investors who participated in the directed share issue of approximately SEK 600 million resolved on 13 June 2024, have undertaken not to utilise the redemption scheme before 2029 and 2026, respectively.

Fore more information, please contact:

Ted Fjällman, CEO of Flerie

E-mail: ir@flerie.com

The information was submitted for publication, through the agency of the contact person above, on 1 July 2025, at 08:00 CEST.

About Flerie

Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com.